Boehringer Ingelheim opens €120M Respimat manufacturing facility in Spain

Boehringer Ingelheim has opened a new €120 million Respimat manufacturing facility in Sant Cugat del Vallés, Spain. The 17,000 sq m plant will produce 25 million units per year and create approximately 200 new jobs.

“The inauguration of this new plant is the recognition of the excellence and professionalism of hundreds of workers who, with their dedication, effort and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s innovation hubs in Europe”oindpnews.com

• 2 sources
• oindpnews.comBoehringer Ingelheim opens new Respimat manufacturing facility – OINDPnewsJun 1, 2019
• dcatvci.orgBI Opens New $135-Million Manufacturing Facility for Respimat Inhaler - DCAT Value Chain InsightsEugeneJun 18, 2019

Summarized from public sources; check the original articles before acting on it.